In this week's roundup, learn about growing support for federal DIR legislation, Congressional hearings exposing PBM tactics, and more!

U.S. Rep. Buddy Carter grills Mylan CEO Heather Bresch during a hearing on Capitol Hill.

In this week's update, new legislation is introduced in the U.S. Senate to end DIR fees, Optum will meet with pharmacies and wholesalers regarding a new policy on distributor accreditation, and more!

In this week's update, learn about efforts to get Medicare to address DIR fees, how to host your federal representatives at your pharmacy during the Congressional recess, and more!

Efforts to show how pharmacy benefit managers (PBMs) negatively affect prescription drug pricing are gaining traction, as shown in a number of recent articles around the country.